Yigong Ge

3.1k citations

36 papers · 2.6k indexed · h-index 28

Impact in

Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Applied Microbiology and Biotechnology top 0.5%
- Antibiotic Use and Resistance

Papers in

Molecular Medicine 18
- Antibiotic Resistance in Bacteria 18
Pharmacology 16
- Antibiotics Pharmacokinetics and Efficacy 16

Co-authors: Shazad Mushtaq David M. Livermore George H. Talbot Michael Zasloff Kenneth J. Holroyd Dorothy L. MacDonald Koné Kaniga Laura Zamorano
Journals: Antimicrobial Agents and Chemotherapy (19 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Diagnostic Microbiology and Infectious Disease (2 papers)Gene (2 papers)International Journal of Antimicrobial Agents (2 papers)
Partner nations: United States Spain France

In The Last Decade

Yigong Ge

36 papers receiving 2.4k citations

Peers

Countries citing papers authored by Yigong Ge

Since Specialization

Citations

This map shows the geographic impact of Yigong Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yigong Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yigong Ge more than expected).

Fields of papers citing papers by Yigong Ge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yigong Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yigong Ge. The network helps show where Yigong Ge may publish in the future.

Co-authors

The 25 scholars most cited alongside Yigong Ge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yigong Ge Line = papers co-authored together Yigong Ge links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Ceftaroline versus Ceftriaxone in a Highly Penicillin-Resistant Pneumococcal Pneumonia Rabbit Model Using Simulated Human Dosing Antimicrobial Agents and Chemotherapy ·Delphine Croisier, Lionel Piroth, Pierre‐Emmanuel Charles, Aurélie Larribeau, Donald Biek, Yigong Ge, P. Chavanet	2011	27
2	In vitro activity of CXA-101 plus tazobactam (CXA-201) against CTX-M-14– and CTX-M-15–producing Escherichia coli and Klebsiella pneumoniae Diagnostic Microbiology and Infectious Disease ·Emilia Titelman, Inga Karlsson, Yigong Ge, Christian G. Giske	2011	50
3	Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins ofPseudomonas aeruginosa Antimicrobial Agents and Chemotherapy ·Bartolomé Moyá, Laura Zamorano, Carlos Juan, Yigong Ge, Antonio Oliver	2010	92
4	Pharmacokinetics and Safety of CXA-101, a New Antipseudomonal Cephalosporin, in Healthy Adult Male and Female Subjects Receiving Single- and Multiple-Dose Intravenous Infusions Antimicrobial Agents and Chemotherapy ·Yigong Ge, M.J. Whitehouse, Ian R. Friedland, George H. Talbot	2010	50
5	Activity of cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa and Burkholderia cepacia group strains and isolates International Journal of Antimicrobial Agents ·David M. Livermore, Shazad Mushtaq, Yigong Ge, Marina Warner	2009	69
6	Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia International Journal of Antimicrobial Agents ·Ian Morrissey, Yigong Ge, Regina Janes	2009	42
7	In Vivo Activity of a Novel Anti-Methicillin-Resistant Staphylococcus aureus Cephalosporin, Ceftaroline, against Vancomycin-Susceptible and -Resistant Enterococcus faecalis Strains in a Rabbit Endocarditis Model: a Comparative Study with Linezolid and Vancomycin Antimicrobial Agents and Chemotherapy ·Cédric Jacqueline, J. Caillon, V. Le Mabecque, A.-F. Miegeville, Yigong Ge, Donald Biek, Éric Batard, G. Potel	2009	24
8	Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients Clinical Microbiology and Infection ·Laura Zamorano, Carlos Juan, Ana FernÃ¡ndez-Olmos, Yigong Ge, Rafael CantÃ n, Antonio Oliver	2009	13
9	Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains Antimicrobial Agents and Chemotherapy ·Carlos Juan, Laura Zamorano, José Luis Pérez, Yigong Ge, Antonio Oliver	2009	80
10	In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes Journal of Antimicrobial Chemotherapy ·Shazad Mushtaq, Marina Warner, Yigong Ge, Koné Kaniga, David M. Livermore	2007	112
11	Molecular characterization of a flagellar/chemotaxis operon in the spirochete Borrelia burgdorferi FEMS Microbiology Letters ·Yigong Ge, Nyles W. Charon	2006	14
12	Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests Journal of Antimicrobial Chemotherapy ·Ronald N. Jones, Thomas R. Fritsche, Yigong Ge, Koné Kaniga, Hélio S. Sader	2005	32
13	In Vitro Activity of Doripenem (S-4661) against Multidrug-Resistant Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis Antimicrobial Agents and Chemotherapy ·Yunhua Chen, Elizabeth Garber, Qi Zhao, Yigong Ge, Matthew A. Wikler, Koné Kaniga, Lisa Saiman	2005	42
14	DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids Bioorganic & Medicinal Chemistry Letters ·Roland W. Bürli, Jacob A. Kaizerman, Jianxin Duan, Peter Jones, Kirk W. Johnson, Mari Iwamoto, Kiet T. V. Truong, Wenhao Hu, Timothy F. Stanton, Alfred Chen, Sofia M. Touami, Matthew Gross, Vernon Jiang, Yigong Ge, Heinz E. Moser	2004	15
15	DNA Binding Ligands with Excellent Antibiotic Potency Against Drug-Resistant Gram-Positive Bacteria Bioorganic & Medicinal Chemistry Letters ·Roland W. Bürli, Yigong Ge, S.W. White, Eldon E. Baird, Sofia M. Touami, Matthew Taylor, Jacob A. Kaizerman, Heinz E. Moser	2002	31
16	A genomic analysis of two‐component signal transduction in Streptococcus pneumoniae Molecular Microbiology ·John Throup, Kristin K. Koretke, Alexander P. Bryant, Karen Ingraham, Alison F. Chalker, Yigong Ge, Andrea Marra, Nicola G. Wallis, James R. Brown, David Holmes, Martin Rosenberg, Martin Burnham	2000	261
17	In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers Diagnostic Microbiology and Infectious Disease ·Yigong Ge, Dorothy L. MacDonald, Marietta M Henry, Howard Hait, Kimberly Nelson, Benjamin A. Lipsky, Michael Zasloff, Kenneth J. Holroyd	1999	92
18	Identification of a large motility operon in Borrelia burgdorferi by semi-random PCR chromosome walking Gene ·Yigong Ge, Nyles W. Charon	1997	27
19	The flgK motility operon of Borrelia burgdorferi is initiated by a s70-like promoter Microbiology ·Yigong Ge, lain G. Old, Saint Girons Isabelle, Nyles W. Charon	1997	47
20	FliH and FliI of Borrelia burgdorferi are similar to flagellar and virulence factor export proteins of other bacteria Gene ·Yigong Ge, Iain G. Old, Isabelle Saint Girons, David B. Yelton, Nyles W. Charon	1996	17

About Yigong Ge

Yigong Ge is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Microbiology and Clinical Biochemistry, having authored 36 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers), Antimicrobial Resistance in Staphylococcus (15 papers), Pneumonia and Respiratory Infections (10 papers), Bacterial Identification and Susceptibility Testing (5 papers), Vector-borne infectious diseases (4 papers), Antimicrobial Peptides and Activities (4 papers) and Cystic Fibrosis Research Advances (3 papers). The work is most often cited by research in Molecular Medicine (958 citations), Applied Microbiology and Biotechnology (259 citations), Microbiology (447 citations), Pharmacology (1.0k citations) and Infectious Diseases (759 citations). Yigong Ge has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Shazad Mushtaq, David M. Livermore, George H. Talbot, Michael Zasloff, Kenneth J. Holroyd, Dorothy L. MacDonald, Koné Kaniga, Laura Zamorano, Carlos Juan and Clyde Thornsberry. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters, Diagnostic Microbiology and Infectious Disease, Gene and International Journal of Antimicrobial Agents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact